Mirum Pharmaceuticals, Inc. MIRM
NASDAQ · United States · Health Technology
$85.13-0.35 (-0.41%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | -1.06 | -0.74 | -42.8% | $176.20M | +5.9% | -9.8%$104.33→$94.11 |
| Q1 2026 | 2026-05-06 | -1.08 | -0.35 | -208.6% | — | — | -2.7%$105.81→$102.93 |
| Q4 2025 | 2026-02-25 | -0.12 | 0.06 | -300.0% | — | — | -14.2%$107.48→$92.19 |
| Q3 2025 | 2025-11-04 | 0.05 | -0.16 | +131.3% | — | — | -1.1%$70.85→$70.09 |
| Q2 2025 | 2025-08-06 | -0.12 | -0.33 | +63.6% | — | — | — |
| Q1 2025 | 2025-05-07 | -0.30 | -0.27 | -11.1% | — | — | — |
| Q4 2024 | 2025-02-26 | -0.49 | -0.25 | -96.0% | — | — | — |
| Q3 2024 | 2024-11-12 | -0.30 | -0.45 | +33.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.